| # | Drug | Count |
|---|---|---|
| 0 | RANIBIZUMAB | 147 |
| 1 | RIBAVIRIN | 98 |
| 2 | PEGINTERFERON ALFA-2A | 80 |
| 3 | BEVACIZUMAB | 72 |
| 4 | AFLIBERCEPT | 62 |
| 5 | BROLUCIZUMAB | 54 |
| 6 | INTERFERON BETA-1A | 47 |
| 7 | ASPIRIN | 41 |
| 8 | ASPIRIN 325 MG | 40 |
| 9 | ASPIRIN 81 MG | 40 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VERTEPORFIN FOR INJECTION | 19 | 0.0128 |
| 1 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 4 | 0.0109 |
| 2 | FERROUS FUMARATE AND POLYSACCHRIDE IRON COMPLEX AND FOLIC ACID | 1 | 0.0104 |
| 3 | AFLIBERCEPT-AYYH | 1 | 0.0099 |
| 4 | INDOCYANINE GREEN | 1 | 0.0083 |
| 5 | TROPICAMIDE | 13 | 0.0080 |
| 6 | TETRACAINE | 3 | 0.0076 |
| 7 | FLUORESCEIN | 4 | 0.0064 |
| 8 | PROPARACAINE HYDROCHLORIDE | 3 | 0.0056 |
| 9 | RANIBIZUMAB | 147 | 0.0055 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 239 |
| 1 | Nucleoside Analog Antiviral [EPC] | 98 |
| 2 | Corticosteroid [EPC] | 72 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 4 | Interferon beta [EPC] | 47 |
| 5 | Insulin Analog [EPC] | 41 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 40 |
| 7 | Benzodiazepine [EPC] | 28 |
| 8 | Alkylating Drug [EPC] | 22 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Diagnostic Dye [EPC] | 4 | 0.0062 |
| 1 | Photoenhancer [EPC] | 19 | 0.0049 |
| 2 | Antiseptic [EPC] | 11 | 0.0025 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 7 | 0.0016 |
| 4 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 239 | 0.0013 |
| 5 | Nucleoside Analog Antiviral [EPC] | 98 | 0.0011 |
| 6 | CD22-directed Immunoconjugate [EPC] | 3 | 0.0010 |
| 7 | Anticholinergic [EPC] | 14 | 0.0009 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 5 | 0.0008 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |